Tag: Columbia University

Poor people participate in cancer trials less often

Your Health Matters

NEW YORK (Reuters Health) – Poor people are less likely to take part in clinical trials for new cancer drugs, which can make it harder to develop treatments, according to a new study. “Cancer clinical trials are how we move the field forward. As a result of patients not participating in clinical trials, it takes a lot longer and it’s much more expensive to develop new therapies,” said Dr. Dawn Hershman, who worked on the study. “In this study we found one factor that contributes to that is patient income,” Hershman, from Columbia University in New York, told Reuters Health. …

, , ,

Many egg-donor recruiters ignore ethical standards

Your Health Matters

NEW YORK (Reuters Health) – A sizable share of the organizations recruiting egg donors online don’t adhere to ethical guidelines laid out by the American Society for Reproductive Medicine (ASRM), according to a new study. “I would argue that there needs to be more attention from ASRM about these agencies, because you don’t want these women exploited,” said Dr. Robert Klitzman, a professor of clinical psychiatry at Columbia University in New York and the study’s senior author. Women are recruited to donate eggs to fulfill a growing demand by couples seeking in vitro fertilization (IVF). …

, , ,

Illumina countersues IBS and Qiagen

Your Health Matters

(Reuters) – Genetic sequencing company Illumina Inc countersued Intelligent Bio-Systems Inc and Qiagen NV alleging infringement on three of its patents expiring in December 2022. Illumina alleged infringement on patents that are applicable to the “sequencing by synthesis technology” being used in the IBS Max-Seq and MINI-20 DNA Sequencers. The company said the suit was in response to the lawsuit brought against Illumina in March by Columbia University and IBS alleging infringement of five patents related to DNA sequencing. Qiagen acquired IBS in June. …

, , ,